{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:47:13Z","timestamp":1792086433917,"version":"4.4.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical and Health Science Program of Zhejiang Province","award":["2025HY0983"],"award-info":[{"award-number":["2025HY0983"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) is a prevalent and lethal liver malignancy, characterized by high recurrence rates and limited therapeutic options. Current diagnostic and treatment strategies are hindered by drug resistance and a lack of effective biomarkers for early detection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study aims to elucidate the role of lactylation and fibroblast cells within the tumor microenvironment (TME) of HCC, focusing on their potential as therapeutic targets. Utilizing a comprehensive multi-omics approach, we integrated single-cell RNA sequencing (scRNA-seq) and single-cell ATAC sequencing (scATAC-seq) data from public databases (GEO, TCGA) to explore transcriptional and epigenetic landscapes at single-cell resolution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our analysis identified fibroblast cells as key players with high lactylation-related pathway activity, and CREB1 as a central transcription factor regulating lactylation-associated genes in these cells. The CREB1 regulatory network was associated with specific immune cell infiltration patterns, drug sensitivity profiles, and enrichment in critical signaling pathways such as Chemokine, TNF, NF-\u03baB, and EMT. These findings underscore the pivotal role of lactylation-driven epigenetic regulation in fibroblasts, influencing the HCC immune microenvironment and disease progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0359329","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:24:32Z","timestamp":1792085072000},"page":"e0359329","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["integrating single-cell transcriptomics and chromatin accessibility profiling to decipher the molecular landscape of Hepatocellular carcinoma"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9489-1635","authenticated-orcid":true,"given":"Kaile","family":"Pan","sequence":"first","affiliation":[{"name":"Wenzhou Medical University","place":["Ningbo, Zhejiang, China"],"department":["Department of General Surgery, Ningbo No. 2 Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijian","family":"Chen","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University","place":["Ningbo, Zhejiang, China"],"department":["Department of General Surgery, Ningbo No. 2 Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5319-9840","authenticated-orcid":true,"given":"Yitao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University","place":["Ningbo, Zhejiang, China"],"department":["Department of General Surgery, Ningbo No. 2 Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"pone.0359329.ref001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"pone.0359329.ref002","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: Profiles, trends, and determinants","volume":"135","author":"C Xia","year":"2022","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"pone.0359329.ref003","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2174\/1874467215666220103111009","article-title":"Potential Therapeutic Strategies to Combat HCC","volume":"15","author":"S Altaf","year":"2022","journal-title":"Curr Mol Pharmacol"},{"issue":"3","key":"pone.0359329.ref004","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/1061186X.2021.1999963","article-title":"Recent advances in hepatocellular carcinoma therapeutic strategies and imaging-guided treatment","volume":"30","author":"Y Du","year":"2022","journal-title":"J Drug Target"},{"issue":"10","key":"pone.0359329.ref005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"JD Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"16","key":"pone.0359329.ref006","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.3748\/wjg.v22.i16.4091","article-title":"Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease","volume":"22","author":"A Ambade","year":"2016","journal-title":"World J Gastroenterol"},{"key":"pone.0359329.ref007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"M Parola","year":"2019","journal-title":"Mol Aspects Med"},{"issue":"3","key":"pone.0359329.ref008","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"PS Ward","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"pone.0359329.ref009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"C Cheng","year":"2018","journal-title":"Cancer Commun (Lond)"},{"issue":"4","key":"pone.0359329.ref010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2174\/0109298665301698240404061300","article-title":"Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease","volume":"31","author":"M Sotoudeheian","year":"2024","journal-title":"Protein Pept Lett"},{"issue":"4","key":"pone.0359329.ref011","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.soc.2019.06.006","article-title":"Evolving Surgical Options for Hepatocellular Carcinoma","volume":"28","author":"GC Wilson","year":"2019","journal-title":"Surg Oncol Clin N Am"},{"issue":"8","key":"pone.0359329.ref012","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1053\/j.gastro.2017.02.040","article-title":"Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality","volume":"152","author":"M Serper","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"pone.0359329.ref013","article-title":"Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis","volume":"17","author":"DT Choi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"pone.0359329.ref014","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/cancers14030649","article-title":"A New Tumor Burden Score and Albumin-Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma","volume":"14","author":"S-Y Ho","year":"2022","journal-title":"Cancers (Basel)"},{"key":"pone.0359329.ref015","doi-asserted-by":"crossref","first-page":"997265","DOI":"10.3389\/fimmu.2022.997265","article-title":"Comprehensive analysis of the clinical significance, immune infiltration, and biological role of MARCH ligases in HCC","volume":"13","author":"J Cao","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"pone.0359329.ref016","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3390\/cancers12071914","article-title":"Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies","volume":"12","author":"MS Makary","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"pone.0359329.ref017","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/cancers12040775","article-title":"Recent Advances in Immunotherapy for Hepatocellular Carcinoma","volume":"12","author":"S Nakano","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"pone.0359329.ref018","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: New trends","volume":"72","author":"AG Singal","year":"2020","journal-title":"J Hepatol"},{"issue":"15","key":"pone.0359329.ref019","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"A Villanueva","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"pone.0359329.ref020","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3390\/cells12151970","article-title":"A Review of Single-Cell RNA-Seq Annotation, Integration, and Cell-Cell Communication","volume":"12","author":"C Cheng","year":"2023","journal-title":"Cells"},{"issue":"6","key":"pone.0359329.ref021","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity","volume":"176","author":"P van Galen","year":"2019","journal-title":"Cell"},{"issue":"1","key":"pone.0359329.ref022","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12967-024-04955-9","article-title":"A multi-dimensional approach to unravel the intricacies of lactylation related signature for prognostic and therapeutic insight in colorectal cancer","volume":"22","author":"H Huang","year":"2024","journal-title":"J Transl Med"},{"key":"pone.0359329.ref023","article-title":"New advances in the diagnosis and management of hepatocellular carcinoma","volume":"371","author":"JD Yang","year":"2020","journal-title":"BMJ"},{"issue":"5","key":"pone.0359329.ref024","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/vaccines9050532","article-title":"The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment","volume":"9","author":"P Leone","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"pone.0359329.ref025","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1007\/s00464-019-06996-4","article-title":"Comparison of clinical outcomes of laparoscopic versus open surgery for recurrent hepatocellular carcinoma: a meta-analysis","volume":"33","author":"W Cai","year":"2019","journal-title":"Surg Endosc"},{"key":"pone.0359329.ref026","doi-asserted-by":"crossref","first-page":"110250","DOI":"10.1016\/j.ejrad.2022.110250","article-title":"Radiofrequency ablation of hepatocellular carcinoma: CT texture analysis of the ablated area to predict local recurrence","volume":"150","author":"A Bele\u00f9","year":"2022","journal-title":"Eur J Radiol"},{"key":"pone.0359329.ref027","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: Management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"issue":"8","key":"pone.0359329.ref028","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2468-1253(23)00147-4","article-title":"Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice","volume":"8","author":"M Pinter","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"pone.0359329.ref029","first-page":"164","article-title":"Multimodal treatment of hepatocellular carcinoma","volume":"61","author":"MM Kirstein","year":"2020","journal-title":"Internist (Berl)"},{"issue":"24","key":"pone.0359329.ref030","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.3748\/wjg.v25.i24.2977","article-title":"Immunotherapy for hepatocellular carcinoma: Current and future","volume":"25","author":"MP Johnston","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"1","key":"pone.0359329.ref031","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00018-024-05144-z","article-title":"BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma","volume":"81","author":"Z Yu","year":"2024","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"pone.0359329.ref032","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1158\/0008-5472.CAN-22-0232","article-title":"MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages","volume":"83","author":"R Dhanasekaran","year":"2023","journal-title":"Cancer Res"},{"issue":"4","key":"pone.0359329.ref033","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2174\/0115665232308821240826075513","article-title":"Proteogenomic Identification and Analysis of KIF5B as a Prognostic Signature for Hepatocellular Carcinoma","volume":"25","author":"L Qi","year":"2025","journal-title":"Curr Gene Ther"},{"issue":"16","key":"pone.0359329.ref034","article-title":"Effects of 3-HAA on HCC by Regulating the Heterogeneous Macrophages-A scRNA-Seq Analysis","volume":"10","author":"C Xue","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"pone.0359329.ref035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12964-023-01357-0","article-title":"Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications","volume":"21","author":"Q Shi","year":"2023","journal-title":"Cell Commun Signal"},{"key":"pone.0359329.ref036","doi-asserted-by":"crossref","first-page":"1070961","DOI":"10.3389\/fimmu.2022.1070961","article-title":"PD-1\/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy","volume":"13","author":"Q Li","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0359329.ref037","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2021.08.029","article-title":"Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B","volume":"76","author":"Y Gao","year":"2022","journal-title":"J Hepatol"},{"issue":"17","key":"pone.0359329.ref038","article-title":"Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin","volume":"186","author":"B Ruf","year":"2023","journal-title":"Cell"},{"issue":"5","key":"pone.0359329.ref039","article-title":"Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics","volume":"43","author":"Y Liu","year":"2025","journal-title":"Cancer Cell"},{"issue":"9","key":"pone.0359329.ref040","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2174\/0109298665330781240830042601","article-title":"Association between Higher Expression of Vav1 in Hepatocellular Carcinoma and Unfavourable Clinicopathological Features and Prognosis","volume":"31","author":"W Ye","year":"2024","journal-title":"Protein Pept Lett"},{"issue":"3","key":"pone.0359329.ref041","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/0113892029313473240919105819","article-title":"CDT1 is a Potential Therapeutic Target for the Progression of NAFLD to HCC and the Exacerbation of Cancer","volume":"26","author":"X He","year":"2025","journal-title":"Curr Genomics"},{"issue":"6","key":"pone.0359329.ref042","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2174\/0113892029277262231108105441","article-title":"Aberrant Expressions of PSMD14 in Tumor Tissue are the Potential Prognostic Biomarkers for Hepatocellular Carcinoma after Curative Resection","volume":"24","author":"Y-M Xiong","year":"2023","journal-title":"Curr Genomics"},{"issue":"1","key":"pone.0359329.ref043","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/0113892029273682240111052317","article-title":"Analysis of the Expression of PRDX6 in Patients with Hepatocellular Carcinoma and its Effect on the Phenotype of Hepatocellular Carcinoma Cells","volume":"25","author":"R Mu","year":"2024","journal-title":"Curr Genomics"},{"key":"pone.0359329.ref044","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429260902230925044009","article-title":"Screening and Identification of ESR1 as a Target of Icaritin in Hepatocellular Carcinoma: Evidence from Bibliometrics and Bioinformatic Analysis","volume":"17","author":"Y Zhou","year":"2024","journal-title":"Curr Mol Pharmacol"},{"issue":"12","key":"pone.0359329.ref045","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1073\/pnas.0501076102","article-title":"Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues","volume":"102","author":"X Zhang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"pone.0359329.ref046","article-title":"CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation","volume":"95","author":"Y Li","year":"2023","journal-title":"J Med Virol"},{"issue":"3","key":"pone.0359329.ref047","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrm3072","article-title":"CREB and the CRTC co-activators: sensors for hormonal and metabolic signals","volume":"12","author":"JY Altarejos","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"pone.0359329.ref048","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35085068","article-title":"Transcriptional regulation by the phosphorylation-dependent factor CREB","volume":"2","author":"B Mayr","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"pone.0359329.ref049","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2005.02.018","article-title":"The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia","volume":"7","author":"DB Shankar","year":"2005","journal-title":"Cancer Cell"},{"key":"pone.0359329.ref050","first-page":"1590717","article-title":"Tuftelin 1 Facilitates Hepatocellular Carcinoma Progression through Regulation of Lipogenesis and Focal Adhesion Maturation","volume":"2022","author":"L Zhu","year":"2022","journal-title":"J Immunol Res"},{"issue":"7","key":"pone.0359329.ref051","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1158\/1078-0432.CCR-20-4391","article-title":"Abiraterone Acetate Induces CREB1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in Prostate Cancer Cells","volume":"27","author":"W Pan","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"5","key":"pone.0359329.ref052","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/1878-0261.12657","article-title":"Norepinephrine-CREB1-miR-373 axis promotes progression of colon cancer","volume":"14","author":"J Han","year":"2020","journal-title":"Mol Oncol"},{"issue":"7","key":"pone.0359329.ref053","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.7150\/ijbs.79583","article-title":"Chronic stress promotes colorectal cancer progression by enhancing glycolysis through \u03b22-AR\/CREB1 signal pathway","volume":"19","author":"Y Guan","year":"2023","journal-title":"Int J Biol Sci"},{"issue":"5","key":"pone.0359329.ref054","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00432-025-06212-y","article-title":"RGS14 promotes the progression of hepatocellular carcinoma by activating the cAMP\/PKA\/CREB signaling pathway","volume":"151","author":"X Liang","year":"2025","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0359329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:24:40Z","timestamp":1792085080000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0359329"}},"subtitle":[],"editor":[{"given":"Tomasz W.","family":"Kaminski","sequence":"first","affiliation":[{"name":"Versiti Blood Research Institute","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":54,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0359329","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}